Vivere Oncotherapies
Unlock the Full Potential of Cancer Immunotherapy
United States · $10.0M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- viveretx.com
- Total Funding
- $10.0M
- Last Round
- $10.0M SeedJan 2026
- Rounds
- 1
About
Biotech developing next-generation gene therapy and immunotherapy for cold solid tumors in oncology.
Summary
Vivere Oncotherapies is a Biotech company based in United States. It has raised $10.0M in total across 1 round, most recently a $10.0M Seed round in Jan 2026. Investors include YK Bioventures, Freeflow Ventures and Pillar VC.
Tech & App Stack
2 technologies & apps tracked
Create a free account to track companies, build lists, and unlock premium data like the full tech & app stack.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Funding History
Jan 2026
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Specialty pharmaceutical company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...